期刊简介

               本刊及时报道国内外分子医学新技术、新知识和新进展,集前瞻性、权威性、专业性于一身的学术期刊,是我国第一份以分子诊断与治疗为主要内容的正规科技学术期刊,也是我国分子诊断与治疗研究领域工作者的学术园地和交流平台,成为我国分子诊断与治疗研究领域工作者在学术上走向世界的桥梁。                

往期目录

首页>分子诊断与治疗杂志
  • 杂志名称:分子诊断与治疗杂志
  • 主管单位:中山大学
  • 主办单位:中山大学
  • 国际刊号:1674-6929
  • 国内刊号:44-1656/R
  • 出版周期:双月刊
期刊荣誉:中国期刊全文数据库(CJFD)期刊收录:上海图书馆馆藏, 国家图书馆馆藏, 维普收录(中), 知网收录(中), 万方收录(中)
分子诊断与治疗杂志2011年第03期

Inhibition of hepatitis C virus core and NS3protein expression by siRNA

关键词:HCV, CORE, NS3, siRNA
摘要:Objective To construct two kinds of plasmids with one for gene expression and the other for RNA expression. Methods Hepatitis C virus(HCV)core and NS3 genes were firstly inserted into the upstream of the reporter genes marked with Rellina(hRluc)luciferase and Firefly luciferase(hluc+).And then the established Plasmids were cotransfected into HEK293 cells. Six short hairpin RNAs targeted HCV core and NS3 genes were designed. and expressed by siRNA expression vector. Inhibition effects with the luminescent intensity were observed. Results Light density in the cells cotransfected with core gene and anti-Core siRNA was obviously weaker, meanwhile. those with NS3 gene and anti-NS3 siRNA had no difference in contrast with the control group. Transfected the anti-NS3 siRNA into the stable expression cells and detected them by real-time PCR and western-blot. The four siRNAs have efficiently suppressed the expression of NS3 at some level. Conclusion The results demonstrated that siRNA Was effective in inhibiting HCV protein expression,and may have therapeutic potential to limit HCV replication in chronically infected patients.